Outpatient Infusion

Feraheme


FERAHEME (also known as Ferumoxytol)

Mechanism:

Feraheme is an iron replacement product.

Indications:

Treatment of iron deficiency anemia in adult patients with chronic kidney disease.

Contraindications:

Patients with active infection should not be started on Feraheme.

Administration:

Feraheme is administered as an infusion and usually repeated 3-8 days later after the first infusion.  Frequency of repeat administration is based on patient’s response.

Copyright by Thrivewell 2017. All rights reserved.